BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Lovastatin, rs3825942, FGF21, nitric oxide metabolic process, HIV infection, Embryo)
Bookmark Forward

QuickView for epstein barr virus nuclear antigens (compound)


Genetic Markers

Most Correlated Genes

  1. TSPAN13
  2. ADAM28
  3. RRM2
  4. HHEX
  5. TGFBR2
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. DODD_NASOPHARYNGEAL_CARCINOMA_DN
  2. KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
  3. FISCHER_DREAM_TARGETS
  4. RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP
  5. cytosol
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Large-scale hypomethylated blocks associated with EBV induced B-cell immortalization
  2. Epstein-Barr virus nuclear antigen 3C (EBNA3C) regulated transformation in lymphoblastoid cell lines
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Sequence variation of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene in chronic lymphocytic l…
  2. EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Mul…
  3. Identification of Potential Inhibitors against Epstein-Barr Virus Nuclear Antigen 1 (EBNA1): An Insi…
  4. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr vi…
  5. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patien…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Comparison of Technics for Determination of Epstein-Barr Virus Serological Diagnosis
  2. Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations
  3. Epstein Barr Virus Infection in Patients With Radiologically Isolated Syndrome
  4. EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases
  5. Transfusion-related EBV Infection Among Allogeneic Stem Cell Transplant Pediatric Recipients
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.